The Journal of Experimental Medicine
Track the topics, authors and articles important to you
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 10 February 2003 doi:10.1084/jem.20021039
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 229K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holloway, A. F.
Right arrow Articles by Shannon, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holloway, A. F.
Right arrow Articles by Shannon, M. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Rockefeller University Press, 0022-1007/2003/2/413 $5.00
The Journal of Experimental Medicine, Volume 197, Number 4, 413-423

Changes in Chromatin Accessibility Across the GM-CSF Promoter upon T Cell Activation Are Dependent on Nuclear Factor {kappa}B Proteins

Adele F. Holloway, Sudha Rao, Xinxin Chen and M. Frances Shannon

Division of Molecular Bioscience, John Curtin School of Medical Research, Australian National University, ACT 2601, Australia

Address correspondence to M. Frances Shannon, Division of Molecular Bioscience, John Curtin School of Medical Research, P.O. Box 334, Canberra ACT 2601, Australia. Phone: 61-(0)2-61259690; Fax: 61-(0)2-61250415; E-mail: frances.shannon{at}anu.edu.au

Granulocyte/macrophage colony-stimulating factor (GM-CSF) is a key cytokine in myelopoiesis and aberrant expression is associated with chronic inflammatory disease and myeloid leukemias. This aberrant expression is often associated with constitutive nuclear factor (NF)-{kappa}B activation. To investigate the relationship between NF-{kappa}B and GM-CSF transcription in a chromatin context, we analyzed the chromatin structure of the GM-CSF gene in T cells and the role of NF-{kappa}B proteins in chromatin remodeling. We show here that chromatin remodeling occurs across a region of the GM-CSF gene between -174 and +24 upon T cell activation, suggesting that remodeling is limited to a single nucleosome encompassing the proximal promoter. Nuclear NF-{kappa}B levels appear to play a critical role in this process. In addition, using an immobilized template assay we found that the ATPase component of the SWI/SNF chromatin remodeling complex, brg1, is recruited to the GM-CSF proximal promoter in an NF-{kappa}B–dependent manner in vitro. These results suggest that chromatin remodeling across the GM-CSF promoter in T cells is a result of recruitment of SWI/SNF type remodeling complexes by NF-{kappa}B proteins binding to the CD28 response region of the promoter.

Key Words: transcription • chromatin remodeling • Brg1 • cytokine • RelA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS